UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000023004
Receipt No. R000026516
Scientific Title Effectiveness of cognitive rehabilitation (NEAR : Neuropsychological and Educational Approach to Cognitive Remediation) on schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorder patients.
Date of disclosure of the study information 2016/08/01
Last modified on 2020/06/02 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effectiveness of cognitive rehabilitation (NEAR : Neuropsychological and Educational Approach to Cognitive Remediation) on schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorder patients.
Acronym Effectiveness of cognitive rehabilitation (NEAR : Neuropsychological and Educational Approach to Cognitive Remediation) on schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorder patients.
Scientific Title Effectiveness of cognitive rehabilitation (NEAR : Neuropsychological and Educational Approach to Cognitive Remediation) on schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorder patients.
Scientific Title:Acronym Effectiveness of cognitive rehabilitation (NEAR : Neuropsychological and Educational Approach to Cognitive Remediation) on schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorder patients.
Region
Japan

Condition
Condition schizophrenia, major depressive disorder, bipolar disorder, and neurodevelopmental disorder
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 effectiveness of cognitive rehabilitation (NEAR : Neuropsychological and Educational Approach to Cognitive Remediation)
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Brief Assessment of Cognition in Schizophrenia: BACS, Self Efficacy for Community Life scale: SECL, Life Assessment Scale for Mental Ill: LASMI, and The Global Assessment of Functioning Scale: GAF after cognitive rehabilitation for 6 months
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Behavior,custom
Interventions/Control_1 cognitive rehabilitation
Interventions/Control_2 twice a week, 6 months
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
49 years-old >=
Gender Male and Female
Key inclusion criteria schizophrenia, major depressive disorder, bipolar disorder, neurodevelopmental disorder patinets
intelligence quotient more than 70 by Wechsler Adult Intelligence Scale- Third Edition, all z score of subscale of Brief Assessment of Cognition in Schizophrenia more than -2
Key exclusion criteria nothing in particular
Target sample size 60

Research contact person
Name of lead principal investigator
1st name Naoya
Middle name
Last name Kitamura
Organization Kawasaki medical school
Division name Depatment of Psychiatry
Zip code 701-0192
Address 577, Matsushima, Kurashiki-city, Okayama 701-0192, Japan
TEL 086-462-1111
Email n-kitamura@med.kawasaki-m.ac.jp

Public contact
Name of contact person
1st name Naoya
Middle name
Last name Kitamura
Organization Kawasaki medical school
Division name Depatment of Psychiatry
Zip code 701-0192
Address 577, Matsushima, Kurashiki-city, Okayama 701-0192, Japan
TEL 086-462-1111
Homepage URL
Email n-kitamura@med.kawasaki-m.ac.jp

Sponsor
Institute Kawasaki medical school department psychiatry
Institute
Department

Funding Source
Organization Kawasaki medical school department psychiatry
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Research ethics committee of Kawasaki Medical School and Kawasaki Medical School Hospital
Address 577, Matsushima, Kurashiki-city, Okayama 701-0192, Japan
Tel 086-462-1111
Email kmsres@med.kawasaki-m.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 6
Results
Results date posted
Results Delayed
Delay expected
Results Delay Reason due to termination of this research
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2016 Year 06 Month 30 Day
Date of IRB
2016 Year 07 Month 11 Day
Anticipated trial start date
2016 Year 08 Month 01 Day
Last follow-up date
2021 Year 07 Month 10 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 07 Month 04 Day
Last modified on
2020 Year 06 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026516